Achilles Therapeutics Plc Stock Overlap Studies MESA Adaptive Moving Average

ACHL Stock  USD 1.08  0.01  0.93%   
Achilles Therapeutics overlap studies tool provides the execution environment for running the MESA Adaptive Moving Average study and other technical functions against Achilles Therapeutics. Achilles Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the MESA Adaptive Moving Average study function is designed to identify and follow existing trends. Achilles Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Fast Limit and Slow Limit to execute this module.

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Achilles Therapeutics PLC price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.

Achilles Therapeutics Technical Analysis Modules

Most technical analysis of Achilles Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Achilles from various momentum indicators to cycle indicators. When you analyze Achilles charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Achilles Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Achilles Therapeutics PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Achilles Therapeutics PLC based on widely used predictive technical indicators. In general, we focus on analyzing Achilles Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Achilles Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Achilles Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Achilles Therapeutics, we also check how macroeconomic factors affect Achilles Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
PB Ratio0.50.180.250.24
Capex To Depreciation2.322.040.230.22
Hype
Prediction
LowEstimatedHigh
0.051.055.63
Details
Intrinsic
Valuation
LowRealHigh
0.153.027.60
Details
3 Analysts
Consensus
LowTargetHigh
8.018.809.77
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.39-0.39-0.39
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Achilles Therapeutics. Your research has to be compared to or analyzed against Achilles Therapeutics' peers to derive any actionable benefits. When done correctly, Achilles Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Achilles Therapeutics PLC.

Align your values with your investing style

In addition to having Achilles Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Momentum Idea
Momentum
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
When determining whether Achilles Therapeutics PLC is a strong investment it is important to analyze Achilles Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Achilles Therapeutics' future performance. For an informed investment choice regarding Achilles Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achilles Therapeutics. If investors know Achilles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achilles Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.66)
Return On Assets
(0.27)
Return On Equity
(0.44)
The market value of Achilles Therapeutics PLC is measured differently than its book value, which is the value of Achilles that is recorded on the company's balance sheet. Investors also form their own opinion of Achilles Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Achilles Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achilles Therapeutics' market value can be influenced by many factors that don't directly affect Achilles Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achilles Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Achilles Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achilles Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.